MENU
ACTU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Actuate Therapeutics (ACTU) Earnings Date & Reports
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3)... Show more
A.I. Advisor
published Earnings
ACTU is expected to report earnings to rise 37.50% to -33 cents per share on September 02
Q2'26
Est.
$-0.33
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.01
Q3'25
Missed
by $0.07
Q2'25
Missed
by $0.11
The last earnings report on May 14 showed earnings per share of -23 cents, beating the estimate of -31 cents. With 178.08K shares outstanding, the current market capitalization sits at 48.81M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information